Brian Ference

Professor, Cardiologist, Director

Contributions

Predictors of residual risk from Lp(a) to apo B89th EAS Congress 2021Mendelian randomizationIntro to Clinical LipidologyGenetics for the identification of therapeutic targets in dyslipidaemiaEAS AC in LipidologyGuidelines - Diabetic patientsAn Introduction to Clinical LipidologyThe genetic evidence for inhibiting the cholesterol synthesis pathway to control LDL cholesterol87th EAS Congress 2019Lessons from genetics - risk-score and novel candidates86th EAS Congress 2018Apo B containing lipoproteins a better target for CV risk reduction?86th EAS Congress 2018Using naturally randomized genetic evidence to understand heritability of coronary artery disease?85th EAS Congress 2017Life time exposure to LDL-cholesterol is it the key to CVD risk?85th EAS Congress 2017

Report

Contains abusive or derogatory content
Contains mature or sensitive content
Contains misleading or false information
Contains spam, fake content or potential malware
Harassment or bullying behavior

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this